Biomarkers for systemic lupus erythematosus disease activity, and intensity and flare
Abstract:
The present invention involves the identification of biomarkers that are predictive of impeding systemic lupus erythematosus (SLE) disease flare. Methods for treating patients so identified are also provided.
Information query
Patent Agency Ranking
0/0